BEMA

BEMA. Or "BEMA Technology" means the drug delivery technology licensed to Arius Pharmaceuticals, Inc., a wholly-owned subsidiary of BDSI ("Arius"), pursuant to (i) that certain License Agreement, dated May 27, 2004, by and between BDSI and QLT USA, Inc. (formerly Atrix Laboratories, Inc.; "Atrix"), as amended (the "Atrix License") and (ii) that certain BEMA License Agreement, dated August 2, 2006, by and between Arius and Arius Two, Inc. ("Arius Two"), a wholly-owned subsidiary of BDSI (the "Arius... Two License"; collectively, the "BEMA Licenses"), as amended. View More

BEMA. Or "BEMA Technology" means the proprietary bioerodible, mucoadhesive multi-layer polymer film technology to which Arius and its Affiliates own exclusive rights, as further described in the patent rights listed on Exhibit A.

BEMA. BDSI's proprietary bioerodible, mucoadhesive multi-layer polymer film technology.